FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / BMC Vet Res / Emergence of carriage of CTX-M-15 in faecal Escherichia coli...
BMC veterinary research2019; 15(1); 268; doi: 10.1186/s12917-019-2011-9

Emergence of carriage of CTX-M-15 in faecal Escherichia coli in horses at an equine hospital in the UK; increasing prevalence over a decade (2008-2017).

Abstract: This study investigated changes over time in the epidemiology of extended-spectrum β-lactamase (ESBL) producing Escherichia coli within a single equine referral hospital in the UK. Faecal samples were collected from hospitalised horses in 2008 and 2017, processed using selective media and standard susceptibility laboratory methods. A novel real-time PCR with high resolution melt analysis was used to distinguish bla and bla within CTX-M-1 group. Results: In 2008, 457 faecal samples from 103 horses were collected, with ESBL-producing E. coli identified in 131 samples (28.7, 95% CI 24.6-33.1). In 2017, 314 faecal samples were collected from 74 horses with ESBL-producing E. coli identified in 157 samples (50.0, 95% CI 44.5-55.5). There were 135 and 187 non-duplicate ESBL-producing isolates from 2008 and 2017, respectively. In 2008, 12.6% of isolates belonged to CTX-M-1 group, all carrying bla, whilst in 2017, 94.1% of isolates were CTX-M-1 group positive and of these 39.2 and 60.8% of isolates carried bla and bla, respectively. In addition, the prevalence of doxycycline, gentamicin and 3rd generation cephalosporin resistance increased significantly from 2008 to 2017 while a decreased prevalence of phenotypic resistance to potentiated sulphonamides was observed. Conclusions: The real-time PCR proved a reliable and high throughput method to distinguish between bla and bla. Furthermore, its use in this study demonstrated the emergence of faecal carriage of CTX-M-15 in hospitalised horses, with an increase in prevalence of ESBL-producing E. coli as well as increased antimicrobial resistance to frequently used antimicrobials.
Get Full Text
Publication Date: 2019-07-29 PubMed ID: 31357996PubMed Central: PMC6664770DOI: 10.1186/s12917-019-2011-9Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article explored the evolution over a decade of extended-spectrum β-lactamase (ESBL) producing Escherichia Coli in a UK-based equine hospital and the growing presence of CTX-M-15 enzyme in fecal samples. Findings indicate an increase in prevalence of ESBL-producing E. coli and heightened antimicrobial resistance.

Methodology

  • Stool samples were collected from horses admitted to the hospital in the years 2008 and 2017.
  • The samples underwent processing using selective media and standard susceptibility techniques in the lab.
  • A real-time Polymerase Chain Reaction (PCR) combined with high resolution melt analysis was used to identify and differentiate the presence of blaCTX-M-14 and blaCTX-M-15 in the CTX-M-1 group of enzymes.

Results

  • In 2008, 457 samples were obtained from 103 horses, 131 of which tested positive for ESBL-producing E. coli.
  • In 2017, 314 samples were taken from 74 horses, 157 of which were positive for ESBL-producing E. coli.
  • The number of unique ESBL-producing samples increased from 135 in 2008 to 187 in 2017.
  • Among the ESBL-positive samples in 2008, 12.6% belonged to the CTX-M-1 group, all carrying blaCTX-M-14.
  • In 2017, however, 94.1% of the ESBL positive samples were part of the CTX-M-1 group, 39.2% of which had blaCTX-M-14 and 60.8% carried blaCTX-M-15.
  • The resistance to three commonly used antimicrobials – doxycycline, gentamicin, and 3rd generation cephalosporin- increased over this period. However, there was a decrease in phenotypic resistance to potentiated sulphonamides.

Conclusions

  • The real-time PCR was described as a reliable, high-throughput technique for distinguishing between blaCTX-M-14 and blaCTX-M-15.
  • The study was able to trace an emergence of CTX-M-15 in fecal samples of hospitalized horses.
  • There is a growing prevalence of ESBL-producing E. coli, signaling increasing antimicrobial resistance as well.

Cite This Article

APA
Isgren CM, Edwards T, Pinchbeck GL, Winward E, Adams ER, Norton P, Timofte D, Maddox TW, Clegg PD, Williams NJ. (2019). Emergence of carriage of CTX-M-15 in faecal Escherichia coli in horses at an equine hospital in the UK; increasing prevalence over a decade (2008-2017). BMC Vet Res, 15(1), 268. https://doi.org/10.1186/s12917-019-2011-9

Publication

BMC veterinary research
ISSN: 1746-6148
NlmUniqueID: 101249759
Country: England
Language: English
Volume: 15
Issue: 1
Pages: 268
PII: 268

Researcher Affiliations

Isgren, C M
  • Institute of Infection and Global Health, University of Liverpool, Neston, England. cisgren@liv.ac.uk.
Edwards, T
  • Research Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, England.
Pinchbeck, G L
  • Institute of Infection and Global Health, University of Liverpool, Neston, England.
Winward, E
  • Research Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, England.
Adams, E R
  • Research Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, England.
Norton, P
  • Research Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, England.
Timofte, D
  • Institute of Infection and Global Health, University of Liverpool, Neston, England.
  • Institute of Veterinary Science, University of Liverpool, Neston, England.
Maddox, T W
  • Department of Musculoskeletal Biology, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, England.
Clegg, P D
  • Department of Musculoskeletal Biology, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, England.
Williams, N J
  • Institute of Infection and Global Health, University of Liverpool, Neston, England.

MeSH Terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Drug Resistance, Bacterial
  • Escherichia coli / drug effects
  • Escherichia coli / enzymology
  • Escherichia coli / genetics
  • Escherichia coli Infections / epidemiology
  • Escherichia coli Infections / microbiology
  • Escherichia coli Infections / veterinary
  • Feces / microbiology
  • Horse Diseases / epidemiology
  • Horse Diseases / microbiology
  • Horses
  • Hospitals, Animal / statistics & numerical data
  • Prevalence
  • United Kingdom / epidemiology
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism

Grant Funding

  • MC_PC_15040 / Medical Research Council
  • MC_PC_16052 / Medical Research Council
  • G2015 / The Horse Trust

Conflict of Interest Statement

The authors declare that they have no competing interests.

References

This article includes 39 references
  1. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.. Clin Infect Dis 2010 Aug 1;51(3):286-94.
    doi: 10.1086/653932pubmed: 20572763google scholar: lookup
  2. Ray S, Anand D, Purwar S, Samanta A, Upadhye KV, Gupta P, Dhar D. Association of high mortality with extended-spectrum β-lactamase (ESBL) positive cultures in community acquired infections.. J Crit Care 2018 Apr;44:255-260.
    doi: 10.1016/j.jcrc.2017.10.036pubmed: 29220754google scholar: lookup
  3. van Spijk JN, Schmitt S, Schoster A. Infections caused by multidrug-resistant bacteria in an equine hospital (2012-2015). Equine Vet Educ 2017.
    doi: 10.1111/eve.12837google scholar: lookup
  4. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, Ayala J, Coque TM, Kern-Zdanowicz I, Luzzaro F, Poirel L, Woodford N. CTX-M: changing the face of ESBLs in Europe.. J Antimicrob Chemother 2007 Feb;59(2):165-74.
    doi: 10.1093/jac/dkl483pubmed: 17158117google scholar: lookup
  5. McNulty CAM, Lecky DM, Xu-McCrae L, Nakiboneka-Ssenabulya D, Chung KT, Nichols T, Thomas HL, Thomas M, Alvarez-Buylla A, Turner K, Shabir S, Manzoor S, Smith S, Crocker L, Hawkey PM. CTX-M ESBL-producing Enterobacteriaceae: estimated prevalence in adults in England in 2014.. J Antimicrob Chemother 2018 May 1;73(5):1368-1388.
    doi: 10.1093/jac/dky007pmc: PMC5909627pubmed: 29514211google scholar: lookup
  6. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, Park YJ, Lavigne JP, Pitout J, Johnson JR. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15.. J Antimicrob Chemother 2008 Feb;61(2):273-81.
    doi: 10.1093/jac/dkm464pubmed: 18077311google scholar: lookup
  7. Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.. Antimicrob Agents Chemother 2004 Jan;48(1):1-14.
    doi: 10.1128/AAC.48.1.1-14.2004pmc: PMC310187pubmed: 14693512google scholar: lookup
  8. Lau SH, Kaufmann ME, Livermore DM, Woodford N, Willshaw GA, Cheasty T, Stamper K, Reddy S, Cheesbrough J, Bolton FJ, Fox AJ, Upton M. UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone.. J Antimicrob Chemother 2008 Dec;62(6):1241-4.
    doi: 10.1093/jac/dkn380pubmed: 18779256google scholar: lookup
  9. Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype.. J Antimicrob Chemother 2017 Aug 1;72(8):2145-2155.
    doi: 10.1093/jac/dkx146pubmed: 28541467google scholar: lookup
  10. Ewers C, Bethe A, Stamm I, Grobbel M, Kopp PA, Guerra B, Stubbe M, Doi Y, Zong Z, Kola A, Schaufler K, Semmler T, Fruth A, Wieler LH, Guenther S. CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence?. J Antimicrob Chemother 2014 May;69(5):1224-30.
    doi: 10.1093/jac/dkt516pubmed: 24398338google scholar: lookup
  11. Cantón R, Coque TM. The CTX-M beta-lactamase pandemic.. Curr Opin Microbiol 2006 Oct;9(5):466-75.
    pubmed: 16942899doi: 10.1016/j.mib.2006.08.011google scholar: lookup
  12. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group.. N Engl J Med 2001 Oct 4;345(14):1007-13.
    doi: 10.1056/NEJMoa011265pubmed: 11586952google scholar: lookup
  13. Apostolakos I, Franz E, van Hoek AHAM, Florijn A, Veenman C, Sloet-van Oldruitenborgh-Oosterbaan MM, Dierikx C, van Duijkeren E. Occurrence and molecular characteristics of ESBL/AmpC-producing Escherichia coli in faecal samples from horses in an equine clinic.. J Antimicrob Chemother 2017 Jul 1;72(7):1915-1921.
    doi: 10.1093/jac/dkx072pubmed: 28333298google scholar: lookup
  14. Dolejska M, Duskova E, Rybarikova J, Janoszowska D, Roubalova E, Dibdakova K, Maceckova G, Kohoutova L, Literak I, Smola J, Cizek A. Plasmids carrying blaCTX-M-1 and qnr genes in Escherichia coli isolates from an equine clinic and a horseback riding centre.. J Antimicrob Chemother 2011 Apr;66(4):757-64.
    doi: 10.1093/jac/dkq500pubmed: 21393204google scholar: lookup
  15. Walther B, Klein KS, Barton AK, Semmler T, Huber C, Wolf SA, Tedin K, Merle R, Mitrach F, Guenther S, Lübke-Becker A, Gehlen H. Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Acinetobacter baumannii among horses entering a veterinary teaching hospital: The contemporary "Trojan Horse".. PLoS One 2018;13(1):e0191873.
    doi: 10.1371/journal.pone.0191873pmc: PMC5790241pubmed: 29381714google scholar: lookup
  16. Ewers C, Grobbel M, Stamm I, Kopp PA, Diehl I, Semmler T, Fruth A, Beutlich J, Guerra B, Wieler LH, Guenther S. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.. J Antimicrob Chemother 2010 Apr;65(4):651-60.
    pubmed: 20118165doi: 10.1093/jac/dkq004google scholar: lookup
  17. Eckert C, Gautier V, Arlet G. DNA sequence analysis of the genetic environment of various blaCTX-M genes.. J Antimicrob Chemother 2006 Jan;57(1):14-23.
    doi: 10.1093/jac/dki398pubmed: 16291869google scholar: lookup
  18. Edwards T, Sasaki S, Williams C, Hobbs G, Feasey NA, Evans K, Adams ER. Speciation of common Gram-negative pathogens using a highly multiplexed high resolution melt curve assay.. Sci Rep 2018 Jan 18;8(1):1114.
    pmc: PMC5773611pubmed: 29348433doi: 10.1038/s41598-017-18915-5google scholar: lookup
  19. Merino I, Hernández-García M, Turrientes MC, Pérez-Viso B, López-Fresneña N, Diaz-Agero C, Maechler F, Fankhauser-Rodriguez C, Kola A, Schrenzel J, Harbarth S, Bonten M, Gastmeier P, Canton R, Ruiz-Garbajosa P. Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe.. J Antimicrob Chemother 2018 Nov 1;73(11):2973-2980.
    doi: 10.1093/jac/dky296pubmed: 30124851google scholar: lookup
  20. Timofte D, Maciuca IE, Williams NJ, Wattret A, Schmidt V. Veterinary Hospital Dissemination of CTX-M-15 Extended-Spectrum Beta-Lactamase-Producing Escherichia coli ST410 in the United Kingdom.. Microb Drug Resist 2016 Oct;22(7):609-615.
    doi: 10.1089/mdr.2016.0036pmc: PMC5073239pubmed: 27314838google scholar: lookup
  21. Pomba C, López-Cerero L, Bellido M, Serrano L, Belas A, Couto N, Cavaco-Silva P, Rodríguez-Baño J, Pascual A. Within-lineage variability of ST131 Escherichia coli isolates from humans and companion animals in the south of Europe.. J Antimicrob Chemother 2014 Jan;69(1):271-3.
    doi: 10.1093/jac/dkt343pubmed: 24022069google scholar: lookup
  22. Pomba C, da Fonseca JD, Baptista BC, Correia JD, Martínez-Martínez L. Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.. Antimicrob Agents Chemother 2009 Jan;53(1):327-8.
    doi: 10.1128/AAC.00896-08pmc: PMC2612186pubmed: 19001117google scholar: lookup
  23. Timofte D, Maciuca IE, Kemmett K, Wattret A, Williams NJ. Detection of the human-pandemic Escherichia coli B2-O25b-ST131 in UK dogs.. Vet Rec 2014 Apr 5;174(14):352.
    doi: 10.1136/vr.101893pubmed: 24570404google scholar: lookup
  24. Roer L, Overballe-Petersen S, Hansen F, Schønning K, Wang M, Røder BL, Hansen DS, Justesen US, Andersen LP, Fulgsang-Damgaard D, Hopkins KL, Woodford N, Falgenhauer L, Chakraborty T, Samuelsen Ø, Sjöström K, Johannesen TB, Ng K, Nielsen J, Ethelberg S, Stegger M, Hammerum AM, Hasman H. Escherichia coli Sequence Type 410 Is Causing New International High-Risk Clones.. mSphere 2018 Jul 18;3(4).
    pmc: PMC6052333pubmed: 30021879doi: 10.1128/msphere.00337-18google scholar: lookup
  25. Guenther S, Grobbel M, Beutlich J, Bethe A, Friedrich ND, Goedecke A, Lübke-Becker A, Guerra B, Wieler LH, Ewers C. CTX-M-15-type extended-spectrum beta-lactamases-producing Escherichia coli from wild birds in Germany.. Environ Microbiol Rep 2010 Oct;2(5):641-5.
    doi: 10.1111/j.1758-2229.2010.00148.xpubmed: 23766249google scholar: lookup
  26. Zong Z, Yu R. Escherichia coli carrying the blaCTX-M-15 gene of ST648.. J Med Microbiol 2010 Dec;59(Pt 12):1536-1537.
    doi: 10.1099/jmm.0.022459-0pubmed: 20724505google scholar: lookup
  27. Critically important antimicrobials for human medicine, 6th revision. 2018. https://www.who.int/foodsafety/publications/antimicrobials-sixth/en/.
  28. Hughes LA, Pinchbeck G, Callaby R, Dawson S, Clegg P, Williams N. Antimicrobial prescribing practice in UK equine veterinary practice.. Equine Vet J 2013 Mar;45(2):141-7.
    doi: 10.1111/j.2042-3306.2012.00602.xpubmed: 22994559google scholar: lookup
  29. Maddox TW, Williams NJ, Clegg PD, O'Donnell AJ, Dawson S, Pinchbeck GL. Longitudinal study of antimicrobial-resistant commensal Escherichia coli in the faeces of horses in an equine hospital.. Prev Vet Med 2011 Jun 15;100(2):134-45.
    doi: 10.1016/j.prevetmed.2011.02.006pubmed: 21377225google scholar: lookup
  30. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, CLSI, 5th Edition. https://clsi.org/standards/products/veterinary-medicine/documents/vet01/.
  31. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.. Clin Microbiol Infect 2012 Mar;18(3):268-81.
    doi: 10.1111/j.1469-0691.2011.03570.xpubmed: 21793988google scholar: lookup
  32. McDaniels AE, Rice EW, Reyes AL, Johnson CH, Haugland RA, Stelma GN Jr. Confirmational identification of Escherichia coli, a comparison of genotypic and phenotypic assays for glutamate decarboxylase and beta-D-glucuronidase.. Appl Environ Microbiol 1996 Sep;62(9):3350-4.
    pmc: PMC168131pubmed: 8795225doi: 10.1128/aem.62.9.3350-3354.1996google scholar: lookup
  33. Batchelor M, Hopkins K, Threlfall EJ, Clifton-Hadley FA, Stallwood AD, Davies RH, Liebana E. bla(CTX-M) genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003.. Antimicrob Agents Chemother 2005 Apr;49(4):1319-22.
    doi: 10.1128/AAC.49.4.1319pmc: PMC1068621pubmed: 15793104google scholar: lookup
  34. Hopkins KL, Batchelor MJ, Liebana E, Deheer-Graham AP, Threlfall EJ. Characterisation of CTX-M and AmpC genes in human isolates of Escherichia coli identified between 1995 and 2003 in England and Wales.. Int J Antimicrob Agents 2006 Sep;28(3):180-92.
    doi: 10.1016/j.ijantimicag.2006.03.027pubmed: 16879949google scholar: lookup
  35. Dallenne C, Da Costa A, Decré D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae.. J Antimicrob Chemother 2010 Mar;65(3):490-5.
    doi: 10.1093/jac/dkp498pubmed: 20071363google scholar: lookup
  36. Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States.. Antimicrob Agents Chemother 2006 Aug;50(8):2872-4.
    pmc: PMC1538681pubmed: 16870791doi: 10.1128/aac.01647-05google scholar: lookup
  37. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, Branger C, Denamur E, Arlet G. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup.. J Antimicrob Chemother 2008 May;61(5):1024-8.
    doi: 10.1093/jac/dkn084pubmed: 18334490google scholar: lookup
  38. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, Boyd D, Mulvey MR, Nordmann P, Ruppé E, Sarthou JL, Frank T, Vimont S, Arlet G, Branger C, Woodford N, Denamur E. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains.. J Antimicrob Chemother 2009 Aug;64(2):274-7.
    pubmed: 19474064doi: 10.1093/jac/dkp194google scholar: lookup
  39. Sergeant E. Epitools epidemiological calculators: Ausvet Pty Ltd; 2019.

Citations

This article has been cited 12 times.
  1. Qin X, Zhang Z. Emergence of a Hybrid IncI1-Iα Plasmid-Encoded bla(CTX-M-101) Conferring Resistance to Cephalosporins in Salmonella enterica Serovar Enteritidis.. Microorganisms 2023 May 12;11(5).
    doi: 10.3390/microorganisms11051275pubmed: 37317249google scholar: lookup
  2. Higgins O, Chueiri A, O'Connor L, Lahiff S, Burke L, Morris D, Pfeifer NM, Santamarina BG, Berens C, Menge C, Caniça M, Manageiro V, Kisand V, Hassan MM, Gardner B, van Vliet AHM, La Ragione RM, Gonzalez-Zorn B, Smith TJ. Portable Differential Detection of CTX-M ESBL Gene Variants, bla(CTX-M-1) and bla(CTX-M-15), from Escherichia coli Isolates and Animal Fecal Samples Using Loop-Primer Endonuclease Cleavage Loop-Mediated Isothermal Amplification.. Microbiol Spectr 2023 Feb 14;11(1):e0331622.
    doi: 10.1128/spectrum.03316-22pubmed: 36511696google scholar: lookup
  3. Bastidas-Caldes C, Romero-Alvarez D, Valdez-Vélez V, Morales RD, Montalvo-Hernández A, Gomes-Dias C, Calvopiña M. Extended-Spectrum Beta-Lactamases Producing Escherichia coli in South America: A Systematic Review with a One Health Perspective.. Infect Drug Resist 2022;15:5759-5779.
    doi: 10.2147/IDR.S371845pubmed: 36204394google scholar: lookup
  4. Perestrelo S, Correia Carreira G, Valentin L, Fischer J, Pfeifer Y, Werner G, Schmiedel J, Falgenhauer L, Imirzalioglu C, Chakraborty T, Käsbohrer A. Comparison of approaches for source attribution of ESBL-producing Escherichia coli in Germany.. PLoS One 2022;17(7):e0271317.
    doi: 10.1371/journal.pone.0271317pubmed: 35839265google scholar: lookup
  5. Akpaka PE, Vaillant A, Wilson C, Jayaratne P. Extended Spectrum Beta-Lactamase (ESBL) Produced by Gram-Negative Bacteria in Trinidad and Tobago.. Int J Microbiol 2021;2021:5582755.
    doi: 10.1155/2021/5582755pubmed: 34475957google scholar: lookup
  6. Singleton DA, Pongchaikul P, Smith S, Bengtsson RJ, Baker K, Timofte D, Steen S, Jones M, Roberts L, Sánchez-Vizcaíno F, Dawson S, Noble PM, Radford AD, Pinchbeck GL, Williams NJ. Temporal, Spatial, and Genomic Analyses of Enterobacteriaceae Clinical Antimicrobial Resistance in Companion Animals Reveals Phenotypes and Genotypes of One Health Concern.. Front Microbiol 2021;12:700698.
    doi: 10.3389/fmicb.2021.700698pubmed: 34394045google scholar: lookup
  7. Bharathwaj M, Webb CT, Vadlamani G, Stubenrauch CJ, Palmer T, Lithgow T. The Carbapenemase BKC-1 from Klebsiella pneumoniae Is Adapted for Translocation by Both the Tat and Sec Translocons.. mBio 2021 Jun 29;12(3):e0130221.
    doi: 10.1128/mBio.01302-21pubmed: 34154411google scholar: lookup
  8. Kauter A, Epping L, Ghazisaeedi F, Lübke-Becker A, Wolf SA, Kannapin D, Stoeckle SD, Semmler T, Günther S, Gehlen H, Walther B. Frequency, Local Dynamics, and Genomic Characteristics of ESBL-Producing Escherichia coli Isolated From Specimens of Hospitalized Horses.. Front Microbiol 2021;12:671676.
    doi: 10.3389/fmicb.2021.671676pubmed: 33936023google scholar: lookup
  9. Valcek A, Sismova P, Nesporova K, Overballe-Petersen S, Bitar I, Jamborova I, Kant A, Hrabak J, Wagenaar JA, Madec JY, Damborg P, van Duijkeren E, Ewers C, Hordijk J, Hasman H, Brouwer MSM, Dolejska M. Horsing around: Escherichia coli ST1250 of equine origin harbouring epidemic IncHI1/ST9 plasmid with bla (CTX-M-1) and an operon for short-chain fructooligosaccharides metabolism.. Antimicrob Agents Chemother 2023 May 1;65(5).
    doi: 10.1128/AAC.02556-20pubmed: 33619063google scholar: lookup
  10. Hansen GT. Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance Among Enterobacterales and Other Gram-Negative Bacteria.. Infect Dis Ther 2021 Mar;10(1):75-92.
    doi: 10.1007/s40121-020-00395-2pubmed: 33492641google scholar: lookup
  11. Shnaiderman-Torban A, Navon-Venezia S, Paitan Y, Archer H, Abu Ahmad W, Bonder D, Hanael E, Nissan I, Zizelski Valenci G, Weese SJ, Steinman A. Extended spectrum β lactamase-producing Enterobacteriaceae shedding by race horses in Ontario, Canada.. BMC Vet Res 2020 Dec 9;16(1):479.
    doi: 10.1186/s12917-020-02701-zpubmed: 33298039google scholar: lookup
  12. Shnaiderman-Torban A, Navon-Venezia S, Dor Z, Paitan Y, Arielly H, Ahmad WA, Kelmer G, Fulde M, Steinman A. Extended-Spectrum β-lactamase-Producing Enterobacteriaceae Shedding in Farm Horses Versus Hospitalized Horses: Prevalence and Risk Factors.. Animals (Basel) 2020 Feb 11;10(2).
    doi: 10.3390/ani10020282pubmed: 32054111google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.